Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
Vascular remodeling is central to the pathophysiology of hypertension and atherosclerosis. Recent evidence suggests that vasoconstrictive substances, such as angiotensin II (AII), may function as a vascular smooth muscle growth promoting substance. To explore the role of the counterregulatory hormon...
Zapisane w:
| Wydane w: | J Clin Invest |
|---|---|
| Główni autorzy: | , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Clinical Investigation
1990
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296921/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2173726/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114893 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|